MGLL and neoplasm: In TAMs isolated from a tumour cell-injected mouse model, monoacylglycerol lipase (MAGL) KO (and presumably reduced degradation of 2-AG) led to enhanced CB2/TLR4-dependent acquisition of an M2-like phenotype, promoting tumour progression [265].